HLA-G and head and neck squamous cell carcinoma: HLA-G is a known inhibitory MHC molecule is recognized by KIRs and LILRB1/2 expressed on NK cells, which represents a possible NK inhibitory axis that is differentially modulated based on viral status of HNSCC (207).